Company: RVRC
Filing Date: 2025-02-14
Form Type: S-1
Source: 0001213900-25-013823
Chunk: 125

Company: Revium Rx.
Filing Date: 2025-02-14
Form: S-1
Chunk 125
---
 – OTHER ACCOUNT PAYABLES

|                                           |     |     Successor |    |     | Predecessor |    |     |              |     |     |      |     |
|                                           |     |     Unaudited |    |     |     Audited |    |     |              |     |     |      |     |
|                                           |     | September 30, |    |     |    July 23, |    |     | December 31, |     |     |      |     |
|                                           |     |          2024 |    |     |        2024 |    |     |         2023 |     |     | 2022 |     |
| Advance on account of shares (*)          |     |               |  - |     |             |  - |     |              |   - |     |      | 200 |
| Accrued expenses                          |     |               | 40 |     |             | 72 |     |              |  90 |     |      |   - |
| Employees and payroll related liabilities |     |               | 37 |     |             |  2 |     |              |  14 |     |      |   - |
| Other                                     |     |               |  8 |     |             | 13 |     |              |   9 |     |      |   - |
| Total                                     |     |               | 85 |     |             | 87 |     |              | 113 |     |      | 200 |

| (*) | On                                                                                                                                   
 August 12, 2022, the Predecessor signed an investment agreement with certain investors for the issuance of 2,000 Ordinary Shares NIS 
 0.1 par value at $100 per share, total consideration of $200. In August 2023, the investor canceled the share purchase agreement and 
 as such the Company returned the investment amount.                                                                                  |

<div align='center'>F-18</div>

REVIUM RX.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

U.S. dollars in thousands, except share and per share data

NOTE 9 – SHAREHOLDERS’ EQUITY

Predecessor

Ordinary shares:

The Ordinary Shares confer upon their holders the right to participate and vote in general shareholder meetings of the Company and to share in the distribution of dividends, if any, declared by the Company from